| Vol. 13.05 – 11 February, 2021 |
| |
|
|
| Researchers demonstrated that α-amanitin–conjugated trastuzumab potentiated the human epidermal growth factor receptor 2 (HER2)-targeted therapy and exhibited superior efficacy in treating HER2-low breast cancer with 17p loss. [Science Translational Medicine] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors showed that tetraarsenic hexoxide induced the pyroptotic cell death through activation of mitochondrial reactive oxygen species (ROS)-mediated caspase-3/gasdermin E (GSDME) pathway, thereby suppressing tumor growth and metastasis of TNBC cells. [Cell Death & Disease] |
|
|
|
| Scientists demonstrated that the alternative splicing event-mediated decrease of very-long-chain ceramides led to enhanced cancer cell proliferation and migration. [Cell Death & Disease] |
|
|
|
| Investigators identified a novel cell subpopulation with an abnormally high expression level of CXCL14 in the positive lymph node of breast cancer patients. [Human Molecular Genetics] |
|
|
|
| Using a V-well cell adhesion assay or flow cytometry analysis with fluorescent beads, the authors found that both TM domain 12-Fc and TM domain 23-Fc inhibited the binding between β1 integrin of human breast cancer-derived cell lines and fibronectin. [Biomedicines] |
|
|
|
| Researchers report that aryl hydrocarbon receptor (AHR) undergone chaperone-mediated autophagy in MDA-MB-468 TNBCs. [International Journal of Molecular Sciences] |
|
|
|
| Using a battery of established breast cancer cell lines with either a well-differentiated epithelial or poorly differentiated mesenchymal phenotype, scientists observed subtype-specific protein expression of RAC1B and RAC1. [Cells] |
|
|
|
| Investigators extended the application of MN-anti-miR10b to a model of breast cancer metastatic to the brain. They demonstrated delivery to the metastatic lesions and obtained evidence of a therapeutic effect manifested as inhibition of metastatic progression. [Scientific Reports] |
|
|
|
| Researchers developed a method to reduce tumor cell aggregation and increased the probability that the observed mammospheres formed were clonal in origin. [Scientific Reports] |
|
|
|
| Investigators report a novel role for PTPα in promoting TNBC cell invasion in vitro and in vivo. They showed that PTPα knockdown reduced extracellular matrix degradation and cellular invasion of MDA-MB-231 cells through Matrigel. [Molecular Biology of the Cell] |
|
|
|
| The authors determined the role of mitochondrial damage in the pathogenicity of K. pneumoniae on bovine mammary epithelial cells, by assessing several classical indicators of mitochondrial dysfunction, as well as differentially expressed genes. [Veterinary Research] |
|
|
|
|
| Scientists discuss clinical perspectives and developments on the use of β-adrenergic receptor inhibitors for breast cancer management and treatment. [Bone Research] |
|
|
|
| Investigators recapitulate the multifaceted action exerted by focal adhesion kinase and its prognostic significance in breast cancer. [Cancers] |
|
|
|
|
| Lassen Therapeutics announced a collaboration with the Olivia Newton-John Cancer Research Institute. The collaboration will study the role of IL-11 signaling and assess the potential of monoclonal antibodies that block IL-11 signaling in preclinical models of TNBC. [Lassen Therapeutics] |
|
|
|
|
| May 17 – 21, 2021 Virtual |
|
|
|
|
|
| Augusta University – Augusta, Georgia, United States |
|
|
|
| Tulane University Health Sciences Center – New Orleans, Louisiana, United States |
|
|
|
| University of Nebraska Medical Center – Omaha, Nebraska, United States |
|
|
|
| KU Leuven – Leuven, Belgium |
|
|
|
| Gilead Sciences, Inc. – London, England, United Kingdom |
|
|
|
|